Alyeska Investment Group
WVE icon

Alyeska Investment Group’s Wave Life Sciences WVE Stock Holding History

Alyeska Investment Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-125,000
Closed -$1.02M – 673
2024
Q3 		$1.02M Buy
+125,000
New +$747K 0.01% 462
2021
Q1 		– Sell
-297,453
Closed -$2.34M – 842
2020
Q4 		$2.34M Sell
297,453
-771,816
-72% -$6.48M 0.03% 357
2020
Q3 		$9.08M Buy
+1,069,269
New +$11.7M 0.14% 191
2017
Q4 		– Sell
-100,599
Closed -$2.19M – 541
2017
Q3 		$2.19M Buy
100,599
+1,798
+2% +$36.1K 0.02% 354
2017
Q2 		$1.84M Buy
+98,801
New +$2.13M 0.02% 356

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Alyeska Investment Group's WVE Position: Q4 2024 in Review

Alyeska Investment Group sold out of Wave Life Sciences (WVE) in Q4 2024, closing a stake of 125,000 shares — an estimated $1.02M sold.

Alyeska Investment Group first reported a position in WVE in Q2 2017 and held it in 5 quarters. The position peaked at $9.08M in Q3 2020. 183 funds tracked by Wall St. Rank hold WVE as of Q4 2024.

  • Alyeska Investment Group reported no remaining Wave Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 125,000 Wave Life Sciences shares in Q4 2024, an estimated $1.02M.
  • Alyeska Investment Group first reported a position in Wave Life Sciences in Q2 2017 and held it in 5 quarters.
  • Alyeska Investment Group's Wave Life Sciences position peaked at $9.08M in Q3 2020.
  • 183 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2024.

Based on Alyeska Investment Group's 13F filing for Q4 2024, filed 14 Feb 2025.